Morphine dependence and withdrawal induced changes in cholinergic signaling
详细信息 查看全文
- 作者：Nichole M. Neugebauer<sup>1sup> ; Emily B. Einstein ; Maria B. Lopez ; Tristan D. McClure-Begley<sup>2sup> ; Yann S. Mineur ; Marina R. Picciotto<sup> ; sup><sup>marina.picciotto@yale.edusup>
- 关键词：Morphine ; Dependence ; Withdrawal ; Acetylcholinesterase ; Nicotine ; Lobeline
- 刊名：Pharmacology Biochemistry and Behavior
- 出版年：2013
- 出版时间：August, 2013
- 年：2013
- 卷：109
- 期：Complete
- 页码：77-83
- 全文大小：585 K
文摘
Cholinergic signaling is thought to be involved in morphine dependence and withdrawal, but the specific mechanisms involved remain unclear. The current study aimed to identify alterations in the cholinergic system that may contribute to the development of morphine dependence and withdrawal. Acetylcholinesterase (AChE) activity and [<sup>3sup>H]-epibatidine binding were evaluated in order to determine if morphine dependence and withdrawal induces alterations in cholinergic signaling or expression of high affinity nicotinic acetylcholine receptors (nAChRs) in the midbrain (MB), medial habenula (MHb) and interpeduncular nucleus (IPN). The effect of cholinergic signaling through nAChRs on morphine-withdrawal induced jumping behavior was then determined. Lastly, the contribution of ¦Â4-containing nAChRs receptors in the MHb to morphine-withdrawal induced jumping behavior and neuronal activity as indicated by c-fos expression was assessed. Chronic morphine administration decreased AChE activity in MB and MHb, an effect that was no longer present following precipitated withdrawal. Morphine dependent mice showed increased nicotinic acetylcholine receptor (nAChR) levels in MB. Further, nicotine (0.4 mg/kg) and lobeline (3 mg/kg) decreased jumping behavior while mecamylamine (1 mg/kg) had no effect. Knock-down of ¦Â4 subunit-containing nAChRs in the MHb attenuated c-fos activation, but did not decrease morphine withdrawal-induced jumping. Thus, morphine withdrawal induces cholinergic signaling in the MHb, but this does not appear to be responsible for the effects of cholinergic drugs on somatic signs of opiate withdrawal, as measured by jumping behavior.